1. < Home

Comparative Effectiveness

Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Crohn’s Disease: 2025 AGA Evidence Synthesis

Singh S, Murad MH, Yuan Y, Ananthakrishnan AN, Click B, Syal G, Haydek JP, Agrawal M, Kappelman MD, Lewis JD, Scott FI. Comparative Efficacy of[...]

By afschroeder • October 21, 2025
Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with 

Fansiwala K, Sauk JS. Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with IBD. Dig Dis Sci. 2024 Dec 20.[...]

By sjmartinez • December 21, 2024
Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis

Ananthakrishnan AN, Murad MH, Scott FI, Agrawal M, Haydek JP, Limketkai BN, Loftus EV Jr, Singh S. Comparative Efficacy of Advanced Therapies for Management of[...]

By sjmartinez • October 20, 2024
Strategies for secondary use of real-world clinical and administrative data for outcome ascertainment in pragmatic clinical trials

Hau C, Woods PA, Guski AS, Raju SI, Zhu L, Alba PR, Cushman WC, Glassman PA, Ishani A, Taylor AA, Ferguson RE, Leatherman SM. Strategies[...]

By sjmartinez • February 22, 2024
Comparative Safety and Effectiveness of Biologic Therapy for Crohn’s Disease: A CA-IBD Cohort Study

Singh S, Kim J, Luo J, Paul P, Rudrapatna V, Park S, Zheng K, Syal G, Ha C, Fleshner P, McGovern D, Sauk JS, Limketkai[...]

By sjmartinez • July 25, 2023